Universal Health (UHS) shares surged 7.40% in after-hours trading on Monday following the company's release of impressive third-quarter results that significantly exceeded analyst expectations. The healthcare services provider reported robust financial performance and raised its full-year 2025 guidance, fueling investor optimism.

For the third quarter, Universal Health reported adjusted earnings per share of $5.69, beating the analyst consensus estimate of $4.79 by a wide margin. This represents a substantial 53.37% increase from the same period last year. The company's quarterly revenue also outperformed expectations, coming in at $4.495 billion, surpassing the estimated $4.345 billion and marking a 13.42% year-over-year growth. The strong performance was attributed to significant growth in acute care services revenue and a $90 million pre-tax reimbursement from the Medicaid program in Washington, D.C.

Adding to the positive sentiment, Universal Health raised its full-year 2025 outlook. The company now expects revenue in the range of $17.31 billion to $17.45 billion, up from previous estimates and above the FactSet consensus of $17.20 billion. Additionally, the adjusted EPS forecast was increased to a range of $21.50 to $22.10, surpassing the FactSet estimate of $20.65. In a further show of confidence, Universal Health announced an increase to its stock repurchase program by $1.5 billion, potentially providing additional support for the stock price in the future.